Authorizes a pharmacy technician or pharmacy intern to perform technology-assisted dispensing process validation for medications prepared for distribution by another pharmacy technician or intern within an institutional pharmacy.
Summary
H5353 amends Rhode Island’s pharmacy laws to allow pharmacy technicians and pharmacy interns, under a licensed pharmacist’s supervision, to perform technology-assisted dispensing process validation in institutional pharmacies. The bill applies to medications prepared by another technician or intern and intended for administration by a licensed health care professional, including patient-specific orders, automated storage and distribution device stock, repackaged unit-dose medications, and emergency kits.
The bill defines key terms such as institutional pharmacy, dispensing process validation, automated storage and distribution devices, and technology (including barcode scanning and RFID). It also limits the new authority by prohibiting delegation for controlled substances and for compounded products unless those products have already been verified by a pharmacist. The pharmacist-in-charge remains responsible for medication errors arising from delegated validation activities, and the Board of Pharmacy is directed to adopt rules for implementation.
Impact
This act creates a new statutory section in chapter 5-19.1 governing pharmacies and expands the scope of practice for pharmacy technicians and pharmacy interns in institutional settings. It requires pharmacies using this authority to maintain written policies, training records, and a continuous quality assessment system, and it authorizes the Board of Pharmacy to promulgate rules and regulations to administer and enforce the new provisions. The law takes effect upon passage and affects institutional pharmacies, pharmacists-in-charge, technicians, interns, and hospital- or clinic-based medication distribution workflows.
Sentiment
The bill appears to have been generally well received, as reflected by strong passage in both chambers. The House passed it 64-5 and the Senate passed it unanimously 35-0, suggesting broad support for the measure’s operational and efficiency goals. No committee transcript was provided, so the available record shows little formal public disagreement.
Contention
The main policy tension in the bill is between expanding technician and intern responsibilities and preserving pharmacist oversight and patient safety. Supporters likely view the measure as a way to improve workflow and use technology to reduce bottlenecks in institutional pharmacies, while the restrictions on controlled substances, compounded products, and discretionary clinical judgment reflect concerns about limiting the delegation to lower-risk tasks. The pharmacist-in-charge’s continuing liability for errors also indicates an effort to address safety and accountability concerns.